Raphael Pharmaceutical (Raphael Pharmaceutical) Price-to-Tangible-Book : (As of Jun. 04, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Raphael Pharmaceutical Price-to-Tangible-Book?

As of today (2024-06-04), Raphael Pharmaceutical's share price is $1.64. Raphael Pharmaceutical's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $-0.01. Hence, Raphael Pharmaceutical's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Raphael Pharmaceutical's Price-to-Tangible-Book or its related term are showing as below:

During the past 4 years, Raphael Pharmaceutical's highest Price to Tangible Book Ratio was 71.43. The lowest was 71.43. And the median was 71.43.

RAPH's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.33
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Raphael Pharmaceutical's share price is $1.64. Raphael Pharmaceutical's Book Value per Sharefor the quarter that ended in Mar. 2024 was $-0.01. Hence, Raphael Pharmaceutical's P/B Ratio of today is .

Raphael Pharmaceutical Price-to-Tangible-Book Historical Data

The historical data trend for Raphael Pharmaceutical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raphael Pharmaceutical Price-to-Tangible-Book Chart

Raphael Pharmaceutical Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

71.43

Raphael Pharmaceutical Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Tangible-Book	Get a 7-Day Free Trial									-	-	-	71.43	-

Competitive Comparison of Raphael Pharmaceutical's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Raphael Pharmaceutical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Raphael Pharmaceutical's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Raphael Pharmaceutical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Raphael Pharmaceutical's Price-to-Tangible-Book falls into.

Raphael Pharmaceutical Price-to-Tangible-Book Calculation

Raphael Pharmaceutical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2024 )
	=	1.64	/	-0.006
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Raphael Pharmaceutical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Raphael Pharmaceutical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Raphael Pharmaceutical (Raphael Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Raphael Pharmaceutical Inc (OTCPK:RAPH) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

4 Lui Paster, Tel Aviv-Jaffa, ISR, 6803605

Website

https://www.raphaelpharmaceutical.com

Raphael Pharmaceutical Inc is a pharmaceutical drug research and development company focused on the discovery and clinical development of life-improving drug therapies based on cannabinoids, including cannabidiol, or CBD oil.

Executives

Joseph Press	director	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Shlomo Pilo	director, 10 percent owner, officer: Chief Executive Officer	4 LUI PASTER, TEL AVIV L3 6803605
Hayon Igal Louria	director, officer: Chief Technology Officer	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Yehuda Eliya	director	4 LUI PASTER, TEL AVIV-JAFFA L3 6803605
Robert B Catell	director	62 OSBORNE ROAD, GARDEN CITY NY 11530
Elisha Yanay	director	C/O ADVANCED TECHNOLOGY ACQUISITION CORP, 14 A ACHIMEIR STREET, RAMAT GAN L3 52587
Yacov A Shamash	director
Guy Ofir	director, 10 percent owner, officer: President	40 BAZ STREET, KARMIEL L3 20100
Emanuel Cohen	director, 10 percent owner, officer: Secretary Treasurer Director	51 BILU STREET, RA'ANANA L3 00000

Raphael Pharmaceutical (Raphael Pharmaceutical) Headlines

No Headlines